Literature DB >> 14500365

Atm-, p53-, and Gadd45a-deficient mice show an increased frequency of homologous recombination at different stages during development.

Alexander J R Bishop1, M Christine Hollander, Bela Kosaras, Richard L Sidman, Albert J Fornace, Robert H Schiestl.   

Abstract

Atm, p53, and Gadd45a form part of a DNA-damage cellular response pathway; the absence of any one of these components results in increased genomic instability. We conducted an in vivo examination of the frequency of spontaneous homologous recombination in Atm-, p53-, or Gadd45a-deficient mice. In the absence of p53, we observed the greatest increase in events, a lesser increase in the absence of Atm, and only a modest increase in the absence of Gadd45a. The striking observation was the difference in the time at which the spontaneous events occurred in atm and trp53 mutant mice. The frequency of homologous recombination in atm mutant mice was increased later during development. In contrast, p53 appears to have a role in suppressing homologous recombination early during development, when p53 is known to spontaneously promote p21 activity. The timing of the increased spontaneous recombination was similar in the Gadd45a- and p53-deficient mice. This temporal resolution suggests that Atm and p53 can act to maintain genomic integrity by different mechanisms in certain in vivo contexts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500365

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Induction of homologous recombination following in utero exposure to DNA-damaging agents.

Authors:  Bijal Karia; Jo Ann Martinez; Alexander J R Bishop
Journal:  DNA Repair (Amst)       Date:  2013-09-10

2.  Genetic Manipulation of Homologous Recombination In Vivo Attenuates Intestinal Tumorigenesis.

Authors:  Michael A McIlhatton; Kevin Murnan; Daniel Carson; Gregory P Boivin; Carlo M Croce; Joanna Groden
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-23

3.  Dissection of a mouse eye for a whole mount of the retinal pigment epithelium.

Authors:  Alison Claybon; Alexander J R Bishop
Journal:  J Vis Exp       Date:  2011-02-27       Impact factor: 1.355

4.  p53-Dependent DNA damage response sensitive to editing-defective tRNA synthetase in zebrafish.

Authors:  Youngzee Song; Yi Shi; Tristan M Carland; Shanshan Lian; Tomoyuki Sasaki; Nicholas J Schork; Steven R Head; Shuji Kishi; Paul Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-08       Impact factor: 11.205

5.  A conditional mouse model for measuring the frequency of homologous recombination events in vivo in the absence of essential genes.

Authors:  Adam D Brown; Alison B Claybon; Alexander J R Bishop
Journal:  Mol Cell Biol       Date:  2011-06-27       Impact factor: 4.272

6.  The antioxidant function of the p53 tumor suppressor.

Authors:  Anna A Sablina; Andrei V Budanov; Galina V Ilyinskaya; Larissa S Agapova; Julia E Kravchenko; Peter M Chumakov
Journal:  Nat Med       Date:  2005-11-13       Impact factor: 53.440

7.  Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.

Authors:  Ramune Reliene; Mitsuko L Yamamoto; P Nagesh Rao; Robert H Schiestl
Journal:  Cancer Res       Date:  2010-11-30       Impact factor: 12.701

8.  p53 suppresses hyper-recombination by modulating BRCA1 function.

Authors:  Chao Dong; Fengmei Zhang; Yue Luo; Hui Wang; Xipeng Zhao; Gongshe Guo; Simon N Powell; Zhihui Feng
Journal:  DNA Repair (Amst)       Date:  2015-06-24

9.  PARP1 suppresses homologous recombination events in mice in vivo.

Authors:  Alison Claybon; Bijal Karia; Crystal Bruce; Alexander J R Bishop
Journal:  Nucleic Acids Res       Date:  2010-07-21       Impact factor: 16.971

Review 10.  Redox regulation of DNA repair: implications for human health and cancer therapeutic development.

Authors:  Meihua Luo; Hongzhen He; Mark R Kelley; Millie M Georgiadis
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.